$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Ramucirumab can significantly prolong the survival of patients with non-small cell lung cancer
2025-10-19 11:44:20
Check Details
Efficacy of rubitidine in the treatment of small cell lung cancer that progresses after platinum-based chemotherapy
2025-10-19 11:44:20
Check Details
Where to buy ramucirumab? How much does it cost?
2025-10-19 11:44:20
Check Details
Small cell lung cancer welcomes new second-line treatment drug - rupitidine
2025-10-19 11:44:20
Check Details
The cost of ramucirumab treatment for patients with lung cancer_Canghule
2025-10-19 11:44:20
Check Details
Ramucirumab effectively improves the survival of metastatic NSCL patients carrying EGFR gene mutations
2025-10-19 11:44:20
Check Details
What are the FDA-approved indications for ramucirumab?
2025-10-19 11:44:20
Check Details
How much does a box of rupees cost? Where can I buy it?
2025-10-19 11:44:20
Check Details
Effects and adverse reactions of ramucirumab in the treatment of non-small cell lung cancer
2025-10-19 11:44:20
Check Details
Ramucirumab combined with docetaxel for metastatic non-small cell lung cancer_Canghule
2025-10-19 11:44:20
Check Details
Safety and effectiveness of rubitidine in the treatment of small cell lung cancer
2025-10-19 11:44:20
Check Details
Which lung cancers can ramucirumab (Cyramza) be used to treat?
2025-10-19 11:44:20
Check Details
1
2
...
3864
3865
3866
3867
3868
3869
3870
...
4152
4153
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer
2
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
3
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI
4
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
5
Cemiplimab (Libtayo) Drug Information
6
Mirvetuximab Soravtansine (Elahere): FRα-Targeted ADC for Platinum-Resistant Ovarian Cancer
7
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
8
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
9
A Revolutionary Targeted Therapy for Hematological Malignancies
10
A New Option for Advanced Renal Cell Carcinoma Treatment
11
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
12
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description: